Literature DB >> 15949722

The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study.

Elfriede Pahl1, David C Naftel, Micheal A Kuhn, Robert E Shaddy, William R Morrow, Charles E Canter, James Kirklin.   

Abstract

BACKGROUND: Transplant coronary artery disease (TCAD) limits survival in heart transplant recipients; however, its incidence in children is unknown. The purpose of this study was to determine the angiographic incidence of TCAD, potential risk factors, and outcomes in a large pediatric cohort.
METHODS: From January 1993 to December 1, a total of 1,222 children, aged newborn to 17 years, underwent primary cardiac transplantation at 20 institutions. A total of 2,049 coronary angiograms were performed in 751 patients. All angiograms were graded for coronary disease and results were submitted to the Pediatric Heart Transplant Study database. We analyzed time-related freedom from graded severity and events from coronary disease, and we examined risk factors.
RESULTS: The incidence of angiographic abnormalities at 1, 3, and 5 years was 2%, 9%, and 17%, respectively; however, moderate-to-severe disease occurred in only 6% at 5 years, compared with 15% in the adult transplant database (p <0.0001). The major risk factors were older recipient and donor age. Two or more episodes of rejection in the 1st year correlated with coronary disease (p = 0.05). Overall freedom from graft loss caused by primary TCAD was 99%, 96%, and 91% at 1, 5, and 9 years after heart transplantation, respectively. Death or graft loss occurred within 2 years of diagnosis in patients with severe disease; 24% of patients with any coronary disease died within 2 years.
CONCLUSIONS: The incidence of TCAD in children is smaller than the incidence in adults, but increases with age. Graft loss is infrequent in children; however, severe coronary disease correlates with poor prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 15949722     DOI: 10.1016/j.healun.2004.03.021

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  19 in total

1.  Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children.

Authors:  Kae Watanabe; Anis Karimpour-Fard; Alix Michael; Shelley D Miyamoto; Stephanie J Nakano
Journal:  J Heart Lung Transplant       Date:  2018-04-30       Impact factor: 10.247

2.  Prognostic significance of recurrent grade 1B rejection in the first year after pediatric cardiac transplantation: a case for reinstatement of the 1B rejection grade.

Authors:  Brian Feingold; Claire Irving; Gregory H Tatum; Steven A Webber
Journal:  Pediatr Transplant       Date:  2011-09

3.  Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction.

Authors:  Bo Ye; Yao Ge; Gregory Perens; Longsheng Hong; Haodong Xu; Michael C Fishbein; Faqian Li
Journal:  Cardiovasc Pathol       Date:  2012-04-02       Impact factor: 2.185

Review 4.  Pediatric heart transplantation: long-term outcomes.

Authors:  Anne I Dipchand; Jessica A Laks
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-29

5.  Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients.

Authors:  Mousumi Moulik; John P Breinholt; William J Dreyer; Debra L Kearney; Jack F Price; Sarah K Clunie; Brady S Moffett; Jeffrey J Kim; Joseph W Rossano; John Lynn Jefferies; Karla R Bowles; E O'Brian Smith; Neil E Bowles; Susan W Denfield; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

6.  Coronary artery spasm during angiography in a pediatric heart transplant recipient: subsequent prevention by intracoronary nitroglycerin administration.

Authors:  Matthew E Ferguson; F Bennett Pearce; Hao H Hsu; Vijay K Misra; James K Kirklin
Journal:  Tex Heart Inst J       Date:  2010

7.  Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.

Authors:  Kevin P Daly; Maria Stack; Michele F Eisenga; John F Keane; David Zurakowski; Elizabeth D Blume; David M Briscoe
Journal:  J Heart Lung Transplant       Date:  2016-10-03       Impact factor: 10.247

8.  Acute myocardial infarction as the presenting symptom of systemic lupus erythematosus.

Authors:  Robin Doyle; James C Perry; Joseph Brennan; John Fahey
Journal:  Pediatr Cardiol       Date:  2009-04-23       Impact factor: 1.655

9.  Systemic effects of intracoronary nitroglycerin during coronary angiography in children after heart transplantation.

Authors:  Diego A Lara; Mary K Olive; James F George; Robert N Brown; Waldemar F Carlo; Edward V Colvin; Brad L Steenwyck; F Bennett Pearce
Journal:  Tex Heart Inst J       Date:  2014-02

10.  Outcome of extracorporeal membrane oxygenation for early primary graft failure after pediatric heart transplantation.

Authors:  Cecile Tissot; Shannon Buckvold; Christina M Phelps; D Dunbar Ivy; David N Campbell; Max B Mitchell; Suzanne Osorio da Cruz; Bill A Pietra; Shelley D Miyamoto
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.